Database

Startups

Main Industry
Biotechnology
Founded Year
2023
Unified Business No.
94185607
Status
Closed
Number of Employees
0
Total Paid-in Capital
1,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Website
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.

Similar Companies

ACEPODIA BIOTECHNOLOGIES, LIMITED

1. ACC (Antibody-Cell Conjugation) technology
2. γδ2 T cell therapy
3. ACE1831
4. ACE2016
5. ACE1708

Rephlmmune Biotechnology Inc.

RephImmune is pioneering a new frontier in cancer immunotherapy with its proprietary platform, Reconstitute-Immunity Antigen-Cell Engager (RACE). This cutting-edge technology is rooted in regeneration biology and is specifically designed to reprogram and

Powin Biomedical Co., Ltd.

Challenges
Economic Losses:

The COVID-19 pandemic has caused significant economic losses exceeding 20 trillion USD globally.

Vaccine Hesitancy:

Despite the introduction of mRNA vaccines, vaccine hesitancy among the public continues to persist.

Evolvin
:::
回頁面最頂端